Evidence map›Paper›PMID 42745543›Full record

ArticleBioinformatics (Oxford, England)2026

PatchEpi: patch-aware equivariant learning improves structure-based epitope prediction.

Sicheng Wen, Fei Li, Yue Qian

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sicheng WenMARS Department, Viva Biotech (Shanghai) Limited, Shanghai 201318, China.ORCID 0009-0000-9992-9140
Fei LiMARS Department, Viva Biotech (Shanghai) Limited, Shanghai 201318, China.ORCID 0000-0003-3685-7164
Yue QianMARS Department, Viva Biotech (Shanghai) Limited, Shanghai 201318, China.ORCID 0000-0003-1989-7586

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

motivationAccurate prediction of B-cell epitopes is essential for antibody design and vaccine development, yet remains fundamentally challenging. A major but often overlooked limitation of existing predictors is their implicit assumption that epitope identity can be decomposed into independent residue-level signals. In contrast, antibody recognition is governed by spatially contiguous surface patches whose functional identity emerges from coherent three-dimensional geometry rather than isolated residues.

resultsHere, we reformulate structure-based B-cell epitope prediction as a surface-patch learning problem and introduce PatchEpi, a patch-aware geometric deep learning framework for antigen-intrinsic epitope modeling. It employs a patch-aware attention encoder and boundary-contrastive objectives to align the learning patch signal with the biological reality of antibody binding. PatchEpi integrates patch embeddings, fine-tuned ESM2 representations, and an equivariant message-passing network to model the 3D topology of antigen surfaces. To enable rigorous evaluation, we created a homology leakage-controlled split by reclustering the ANABAG dataset. Across multiple benchmarks, PatchEpi consistently outperforms residue-centric and graph-based state-of-the-art methods. Structural analyses further show that the model learns coherent surface patches that closely match experimentally resolved antibody footprints. These results demonstrate that accurate epitope prediction benefits primarily from reformulating the task around surface-patch learning. Patch-aware learning provides a principled and biologically grounded pathway toward more reliable structure-based epitope detection. AVAILABILITY AND IMPLEMENTATION: The code and related resources are available at GitHub (https://github.com/wsicheng739/PatchEpi) and Zenodo (https://doi.org/10.5281/zenodo.20366444).

Indexed as

Computational BiologyDeep LearningEpitopes, B-LymphocyteModels, MolecularEpitopes, B-Lymphocyte

Identifiers

PMID42745543
PMCPMC13613061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.